Início › Câncer de Pâncreas › Texas › Dallas
Ensaios clínicos de Câncer de Pâncreas em Dallas, TX
22 estudos para Câncer de Pâncreas estão buscando participantes em locais em Dallas e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
DESTINY-PANTUMOUR04
RecrutandoEstudo observacional
- Research Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecrutandoFase 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- e mais 1
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RecrutandoFase 3
- Texas Oncology - DFW, Dallas
- University of Texas, Southwestern Medical Center, Dallas
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RecrutandoFase 3
- Investigative Site US067, Dallas
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RecrutandoFase 3
- UT Southwestern Medical Center at Dallas, Dallas
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RecrutandoFase 1
- NEXT - Dallas, Dallas
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RecrutandoEstudo observacional
- University of Texas Southwestern/Children's Medical Center, Dallas
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RecrutandoEstudo observacional
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
RecrutandoFase 1
- University of Texas Southwestern Medical Center, Dallas
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RecrutandoFase 1
- Ut Southwestern, Dallas
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RecrutandoFase 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
RecrutandoFase 3
- University of Texas Southwestern Medical Center, Dallas
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
RecrutandoFase 2
- Texas Oncology - DFW, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Mary Crowley Cancer Research, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
RecrutandoEstudo observacional
- Methodist Dallas Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- NEXT Oncology - Dallas, Dallas
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RecrutandoFase 2
- Ohio State University-Telemedicine, Dallas
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
RecrutandoFase 1/2
- NEXT Oncology Dallas, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RecrutandoFase 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
RecrutandoEstudo observacional
- Methodist Digestive Institute, Dallas
Ensaios de Câncer de Pâncreas em outras cidades
- Houston, TX61 estudos
- New York City, NY60 estudos
- Boston, MA43 estudos
- Nashville, TN39 estudos
- Los Angeles, CA35 estudos
- St. Louis, MO33 estudos
- Arlington, VA33 estudos
- Baltimore, MD31 estudos
- San Antonio, TX31 estudos
- Philadelphia, PA26 estudos
- Tampa, FL26 estudos
- Durham, NC24 estudos
Outros estudos em Dallas
- Câncer de Mama55 estudos
- Câncer de Pulmão de Não Pequenas Células52 estudos
- Câncer Metastático42 estudos
- Insuficiência Cardíaca42 estudos
- Câncer (todos os tipos)37 estudos
- Câncer de Próstata36 estudos
- Câncer Colorretal33 estudos
- Obesidade30 estudos
- Câncer de Ovário28 estudos
- Câncer de Pulmão27 estudos
- Câncer de Bexiga27 estudos
- Câncer Endometrial24 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.